coronavirus September 10, 2020 2:50 pm

Final Phase of Vaccine Trial Paused After Neurological Symptoms Surfaced

AstraZeneca announced late Tuesday that it is pausing its crucial late-stage trial for its coronavirus vaccine candidate as a result of a patient illness. This comes a day after several companies signed a safety pledge to uphold the scientific standards that their experimental vaccines will be held against.

Local

0:44

Virginia gov. sends resources to firefighters battling wildfires
2:12

Recording studio shooting marks Laurel's first homicides of 2024
1:22

Maryland designer behind Hanifa hopes her journey inspires
1:58

MedStar Health gives $100,000 in scholarships to Marymount University physical therapy students
2:34

How AI is being used on Prince George's roads to improve safety
Exit mobile version